Gregory Burton, MD
Physical Medicine and Rehabilitation · Bellaire, TXNPI 1215913660
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $915 and has fallen 62.5% since, to $343 in 2025.
Across 37 payments — averaging $51.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$255
- AstraZeneca$249
- Teva Pharmaceuticals USA, Inc.$243
- Johnson & Johnson$238
- Novo Nordisk$230
- Neurocrine Biosciences, Inc.$124
- plus $577 from 11 others
What the payments were for
- Food & beverage$1,915100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $255 |
| AstraZeneca(2 entities) | 3 | $249 |
| Teva Pharmaceuticals USA, Inc. | 7 | $243 |
| Johnson & Johnson | 2 | $238 |
| Novo Nordisk | 3 | $230 |
| Neurocrine Biosciences, Inc. | 2 | $124 |
| Kyowa Kirin, Inc. | 1 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Sanofi-aventis U.S. LLC | 1 | $75 |
| Ipsen Biopharmaceuticals, Inc | 4 | $64 |
| Saol Therapeutics Inc. | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| GRT US Holding, Inc. | 1 | $41 |
| Merz North America, Inc. | 1 | $20 |
| Novartis | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,915 in reported general payments places this provider in the 85th percentile of 651 physical medicine and rehabilitation providers in Texas.
See all physical medicine and rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physical medicine and rehabilitation in Bellaire
- Cindy TiuBellaire$13K
- Gerard FranciscoHouston$364K
- Jose UrquidezAustin$332K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
- Sheng LiHouston$44K
- Mary RussellShenandoah$37K
- Randall WolcottLubbock$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.